Reuters
In an article on the U.S. Supreme Court’s June 18, 2012 decision in Christopher v. SmithKline, Littler’s Lee Schreter commented on the holding that pharmaceutical sales representatives were properly classified as exempt from overtime pay. She notes that nearly every major pharmaceutical manufacturer has faced similar lawsuits in a dispute that had threatened the industry with billions of dollars in potential liability.
